Overview

First-in-man Imaging of a New PET Radiotracer for Oxytocin Receptors

Status:
COMPLETED
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The investigators will test a new positron-emitting radiotracer to determine whether it is suitable for studying the oxytocin receptor by positron emission tomography (PET) in humans. If suitable, the radiotracer will be used to study the brain and trigeminal nerve in several disorders.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Aarhus University Hospital
Collaborator:
Tonix Pharmaceuticals, Inc.